MS

Meena Saji

Director Director DIN 01649189
DIN 01649189 First appointment Jul 2005 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jul 2005
Shareholding value Locked Premium profile

About Meena Saji

Meena Saji has 21 years in corporate governance. Formerly with 1 company, such as Pharmacopius Drugs Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 01649189
Primary Designation Director
First Appointment 13 Jul 2005
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Pharmacopius Drugs Private Limited U24232KL2005PTC018418
Managing Director 13 Jul 2005 2005 Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Pharmacopius Drugs Private Limited
Premium access

Shareholding and investment profile for Meena Saji

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Meena Saji

Meena Saji has 21 years in corporate governance. Formerly with 1 company, such as Pharmacopius Drugs Private Limited. Engaged in General Business. Contributes to corporate operations.

Meena Saji is associated with 0 companies as a director.

Meena Saji has expertise in General Business.

Meena Saji has 21 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available